Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology
The need for biomarkers for acute ischemic stroke (AIS) to understand the mechanisms implicated in pathological clot formation is critical. The levels of the brain natriuretic peptides known as brain natriuretic peptide (BNP) and NT-proBNP have been shown to be increased in patients suffering from heart failure and other heart conditions. We measured their expression in AIS clots of cardioembolic (CE) and large artery atherosclerosis (LAA) etiology, evaluating their location inside the clots, aiming to uncover their possible role in thrombosis. We analyzed 80 thrombi from 80 AIS patients in the RESTORE registry of AIS clots, 40 of which were of CE and 40 of LAA etiology. The localization of BNP and NT-BNP, quantified using immunohistochemistry and immunofluorescence, in AIS-associated white blood cell subtypes was also investigated. We found a statistically significant positive correlation between BNP and NT-proBNP expression levels (Spearman's rho = 0.668 p < 0.0001 *). We did not observe any statistically significant difference between LAA and CE clots in BNP expression (0.66 [0.13-3.54]% vs. 0.53 [0.14-3.07]%, p = 0.923) or in NT-proBNP expression (0.29 [0.11-0.58]% vs. 0.18 [0.05-0.51]%, p = 0.119), although there was a trend of higher NT-proBNP expression in the LAA clots. It was noticeable that BNP was distributed throughout the thrombus and especially within platelet-rich regions. However, NT-proBNP colocalized with neutrophils, macrophages, and T-lymphocytes, suggesting its association with the thrombo-inflammatory process.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
International journal of molecular sciences - 25(2024), 5 vom: 05. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rossi, Rosanna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
114471-18-0 |
|---|
| Anmerkungen: |
Date Completed 14.03.2024 Date Revised 15.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijms25052999 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369639596 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369639596 | ||
| 003 | DE-627 | ||
| 005 | 20240315233830.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240313s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms25052999 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1330.xml |
| 035 | |a (DE-627)NLM369639596 | ||
| 035 | |a (NLM)38474245 | ||
| 035 | |a (PII)2999 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rossi, Rosanna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2024 | ||
| 500 | |a Date Revised 15.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The need for biomarkers for acute ischemic stroke (AIS) to understand the mechanisms implicated in pathological clot formation is critical. The levels of the brain natriuretic peptides known as brain natriuretic peptide (BNP) and NT-proBNP have been shown to be increased in patients suffering from heart failure and other heart conditions. We measured their expression in AIS clots of cardioembolic (CE) and large artery atherosclerosis (LAA) etiology, evaluating their location inside the clots, aiming to uncover their possible role in thrombosis. We analyzed 80 thrombi from 80 AIS patients in the RESTORE registry of AIS clots, 40 of which were of CE and 40 of LAA etiology. The localization of BNP and NT-BNP, quantified using immunohistochemistry and immunofluorescence, in AIS-associated white blood cell subtypes was also investigated. We found a statistically significant positive correlation between BNP and NT-proBNP expression levels (Spearman's rho = 0.668 p < 0.0001 *). We did not observe any statistically significant difference between LAA and CE clots in BNP expression (0.66 [0.13-3.54]% vs. 0.53 [0.14-3.07]%, p = 0.923) or in NT-proBNP expression (0.29 [0.11-0.58]% vs. 0.18 [0.05-0.51]%, p = 0.119), although there was a trend of higher NT-proBNP expression in the LAA clots. It was noticeable that BNP was distributed throughout the thrombus and especially within platelet-rich regions. However, NT-proBNP colocalized with neutrophils, macrophages, and T-lymphocytes, suggesting its association with the thrombo-inflammatory process | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a BNP | |
| 650 | 4 | |a NT-proBNP | |
| 650 | 4 | |a acute ischemic stroke | |
| 650 | 4 | |a brain natriuretic peptide | |
| 650 | 4 | |a stroke biomarkers | |
| 650 | 4 | |a stroke etiology | |
| 650 | 4 | |a thrombus | |
| 650 | 7 | |a Natriuretic Peptide, Brain |2 NLM | |
| 650 | 7 | |a 114471-18-0 |2 NLM | |
| 650 | 7 | |a Peptide Fragments |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Jabrah, Duaa |e verfasserin |4 aut | |
| 700 | 1 | |a Douglas, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Prendergast, James |e verfasserin |4 aut | |
| 700 | 1 | |a Pandit, Abhay |e verfasserin |4 aut | |
| 700 | 1 | |a Gilvarry, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a McCarthy, Ray |e verfasserin |4 aut | |
| 700 | 1 | |a Redfors, Petra |e verfasserin |4 aut | |
| 700 | 1 | |a Nordanstig, Annika |e verfasserin |4 aut | |
| 700 | 1 | |a Tatlisumak, Turgut |e verfasserin |4 aut | |
| 700 | 1 | |a Ceder, Erik |e verfasserin |4 aut | |
| 700 | 1 | |a Dunker, Dennis |e verfasserin |4 aut | |
| 700 | 1 | |a Carlqvist, Jeanette |e verfasserin |4 aut | |
| 700 | 1 | |a Szikora, István |e verfasserin |4 aut | |
| 700 | 1 | |a Tsivgoulis, Georgios |e verfasserin |4 aut | |
| 700 | 1 | |a Psychogios, Klearchos |e verfasserin |4 aut | |
| 700 | 1 | |a Thornton, John |e verfasserin |4 aut | |
| 700 | 1 | |a Rentzos, Alexandros |e verfasserin |4 aut | |
| 700 | 1 | |a Jood, Katarina |e verfasserin |4 aut | |
| 700 | 1 | |a Juega, Jesus |e verfasserin |4 aut | |
| 700 | 1 | |a Doyle, Karen M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 25(2024), 5 vom: 05. März |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2024 |g number:5 |g day:05 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms25052999 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2024 |e 5 |b 05 |c 03 | ||